These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 19256469

  • 1. Catalytic properties of botulinum neurotoxin subtypes A3 and A4.
    Henkel JS, Jacobson M, Tepp W, Pier C, Johnson EA, Barbieri JT.
    Biochemistry; 2009 Mar 24; 48(11):2522-8. PubMed ID: 19256469
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A structural perspective of the sequence variability within botulinum neurotoxin subtypes A1-A4.
    Arndt JW, Jacobson MJ, Abola EE, Forsyth CM, Tepp WH, Marks JD, Johnson EA, Stevens RC.
    J Mol Biol; 2006 Sep 29; 362(4):733-42. PubMed ID: 16938310
    [Abstract] [Full Text] [Related]

  • 4. Holotoxin Activity of Botulinum Neurotoxin Subtype A4 Originating from a Nontoxigenic Clostridium botulinum Expression System.
    Bradshaw M, Tepp WH, Whitemarsh RC, Pellett S, Johnson EA.
    Appl Environ Microbiol; 2014 Dec 29; 80(23):7415-22. PubMed ID: 25239905
    [Abstract] [Full Text] [Related]

  • 5. The Light Chain Defines the Duration of Action of Botulinum Toxin Serotype A Subtypes.
    Pellett S, Bradshaw M, Tepp WH, Pier CL, Whitemarsh RCM, Chen C, Barbieri JT, Johnson EA.
    mBio; 2018 Mar 27; 9(2):. PubMed ID: 29588398
    [Abstract] [Full Text] [Related]

  • 6. Unique substrate recognition by botulinum neurotoxins serotypes A and E.
    Chen S, Barbieri JT.
    J Biol Chem; 2006 Apr 21; 281(16):10906-11. PubMed ID: 16478727
    [Abstract] [Full Text] [Related]

  • 7. Crystal structure of the catalytic domain of botulinum neurotoxin subtype A3.
    Leka O, Wu Y, Li X, Kammerer RA.
    J Biol Chem; 2021 Apr 21; 296():100684. PubMed ID: 33891946
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Analysis of the neurotoxin complex genes in Clostridium botulinum A1-A4 and B1 strains: BoNT/A3, /Ba4 and /B1 clusters are located within plasmids.
    Smith TJ, Hill KK, Foley BT, Detter JC, Munk AC, Bruce DC, Doggett NA, Smith LA, Marks JD, Xie G, Brettin TS.
    PLoS One; 2007 Dec 05; 2(12):e1271. PubMed ID: 18060065
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A DARPin promotes faster onset of botulinum neurotoxin A1 action.
    Leka O, Wu Y, Zanetti G, Furler S, Reinberg T, Marinho J, Schaefer JV, Plückthun A, Li X, Pirazzini M, Kammerer RA.
    Nat Commun; 2023 Dec 18; 14(1):8317. PubMed ID: 38110403
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Purification and characterization of a novel subtype a3 botulinum neurotoxin.
    Tepp WH, Lin G, Johnson EA.
    Appl Environ Microbiol; 2012 May 18; 78(9):3108-13. PubMed ID: 22367089
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The C-terminus of botulinum neurotoxin type A light chain contributes to solubility, catalysis, and stability.
    Baldwin MR, Bradshaw M, Johnson EA, Barbieri JT.
    Protein Expr Purif; 2004 Sep 18; 37(1):187-95. PubMed ID: 15294297
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Glycine insertion at protease cleavage site of SNAP25 resists cleavage but enhances affinity for botulinum neurotoxin serotype A.
    Ho M, Goh CH, Brothers MC, Wang S, Young RL, Ou Y, Lui JN, Kalafatis M, Lan X, Wolf AE, Rienstra CM, Wilson BA.
    Protein Sci; 2012 Mar 18; 21(3):318-26. PubMed ID: 22170566
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.